New Report Details Mounting Testosterone Lawsuit Filings in Federal Litigation Where Bernstein Liebhard LLP Represents a Number of Plaintiffs

New York, New York (PRWEB) March 17, 2015

Testosterone lawsuit ( filings continue to grow in the federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois, where Bernstein Liebhard LLP is representing a number of plaintiffs. Court records indicate that the U.S. Judicial Panel on Multidistrict Litigation (JMPL) released a new Docket Report on March 16, 2014, which noted that 1,172, product liability claims are currently pending in the proceeding, all of which were filed on behalf of men who allegedly experienced heart attacks, strokes, blood clots and other serious cardiovascular complications due to their use of prescription testosterone replacement products. The JPMLs previous report issued on February 17th noted a total of 1,017 cases, indicating that 155 new testosterone treatment lawsuits have been filed in the proceeding over the past month. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)

Over the past year, our Firm has heard from numerous men who claim to have suffered life-threatening cardiovascular injuries due to prescription testosterone treatments, so we are not surprised that new cases continue to be filed in this proceeding. We are pleased that the litigation involving these medications is progressing, and look forward to further progress in the months to come, says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently representing a number of clients who have testosterone lawsuits pending in the federal proceeding, and continues to offer free case reviews to men who may have been harmed by low testosterone treatments.

Testosterone Litigation

According to court documents, the JPML created the federal testosterone litigation in June 2014, initially transferring four dozen cases to the Northern District of Illinois. The Panels June 6th Order noted that all of the actions transferred at that time were filed in the wake of the U.S. Food & Drug Administrations (FDA) January 31, 2014 announcement that it was reviewing the cardiovascular risks allegedly associated with testosterone therapy.* On March 3, 2015, the FDA updated its alert, and ordered the manufacturers of prescription testosterone treatments to add new information to their labels regarding the drugs potential to increase a patients risk for heart attacks and strokes. The FDA also mandated that the labels be modified to make it clear that this class of medications has not been approved to treat low testosterone levels merely associated with the male aging process. Rather, testosterone therapy is only approved to treat hypogonadism (low testosterone) associated with certain medical conditions.

Court records indicate that all of the testosterone lawsuits pending in Illinois allege that the drugs manufacturers concealed their association with serious cardiovascular problems, including heart attacks, strokes, deep vein thrombosis, and pulmonary embolism. The defendants are also accused of allegedly wrongly marketing testosterone replacement products as remedies for low libido, loss of muscle mass, weight gain, fatigue, and other issues associated with age-related drops in testosterone.

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages.

To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP’s website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*, FDA, January 31, 2014

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $ 3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016



Leave a Reply